Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Anthony J Garcia-Prats"'
Autor:
Thomas Wilkinson, Anthony J Garcia-Prats, Tina Sachs, Mandar Paradkar, Nishi Suryavanshi, Aarti Kinikar, Melchor V Frias, Edina Sinanovic, Anneke C Hesseling, James A Seddon, Megan Palmer
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0305930 (2024)
Rifampicin-resistant (RR) tuberculosis (TB) in children is a major global health concern but is often neglected in economics research. Accurate cost estimations across the spectrum of paediatric RR-TB treatment regimens are critical inputs for priori
Externí odkaz:
https://doaj.org/article/a0c7987511264d60855c8ce322808fdf
Autor:
Dillon T Wademan, Megan Palmer, Susan Purchase, Marieke M van der Zalm, Muhammad Osman, Anthony J Garcia-Prats, James A Seddon, H Simon Schaaf, Anneke C Hesseling, Ria Reis, Lindsey J Reynolds, Graeme Hoddinott
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 12, p e0001267 (2022)
To describe an early-stage holistic framework towards evaluating factors that impact the overall acceptability of TB treatment along the TB care cascade in children. We developed a conceptual framework utilising a theory generative approach. Domains
Externí odkaz:
https://doaj.org/article/9f74b535ddea4f8a93270014e331dbda
Autor:
Dillon T Wademan, Graeme Hoddinott, Susan E Purchase, James A Seddon, Anneke C Hesseling, Anthony J Garcia-Prats, Ria Reis, Lindsey J Reynolds
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0268560 (2022)
Drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb) are increasingly recognised as a threat to global tuberculosis (TB) control efforts. Identifying people with DR-TB exposure/ infection and providing TB preventive therapy (TPT) is a pu
Externí odkaz:
https://doaj.org/article/60c967ce2a084da5834e985a8505069c
Autor:
Amita Gupta, Michael D Hughes, Anthony J Garcia-Prats, Katherine McIntire, Anneke C Hesseling
Publikováno v:
PLoS Medicine, Vol 16, Iss 8, p e1002882 (2019)
Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.
Externí odkaz:
https://doaj.org/article/345d97c792f64bf58393bd91f73dbf40
Autor:
Anthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, Maria Garcia-Cremades, Jana Winckler, Lubbe Wiesner, Anneke C Hesseling, Rada M Savic
Publikováno v:
PLoS Medicine, Vol 16, Iss 4, p e1002789 (2019)
BackgroundLinezolid is increasingly important for multidrug-resistant tuberculosis (MDR-TB) treatment. However, among children with MDR-TB, there are no linezolid pharmacokinetic data, and its adverse effects have not yet been prospectively described
Externí odkaz:
https://doaj.org/article/8d08cb30f6e141efb145fc8d24fc1934
Autor:
Elizabeth P Harausz, Anthony J Garcia-Prats, Stephanie Law, H Simon Schaaf, Tamara Kredo, James A Seddon, Dick Menzies, Anna Turkova, Jay Achar, Farhana Amanullah, Pennan Barry, Mercedes Becerra, Edward D Chan, Pei Chun Chan, Domnica Ioana Chiotan, Aldo Crossa, Peter C Drobac, Lee Fairlie, Dennis Falzon, Jennifer Flood, Medea Gegia, Robert M Hicks, Petros Isaakidis, S M Kadri, Beate Kampmann, Shabir A Madhi, Else Marais, Andrei Mariandyshev, Ana Méndez-Echevarría, Brittany Kathryn Moore, Parpieva Nargiza, Iveta Ozere, Nesri Padayatchi, Saleem- Ur-Rehman, Natasha Rybak, Begoña Santiago-Garcia, N Sarita Shah, Sangeeta Sharma, Tae Sun Shim, Alena Skrahina, Antoni Soriano-Arandes, Martin van den Boom, Marieke J van der Werf, Tjip S van der Werf, Bhanu Williams, Elena Yablokova, Jae-Joon Yim, Jennifer Furin, Anneke C Hesseling, Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB
Publikováno v:
PLoS Medicine, Vol 15, Iss 7, p e1002591 (2018)
BackgroundAn estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optimal treatment for these children.Methods and findingsTo
Externí odkaz:
https://doaj.org/article/742073f7e5a241848b127ed1331e1595
Autor:
Muhammad Osman, Elizabeth P. Harausz, Anthony J. Garcia-Prats, H. Simon Schaaf, Brittany K. Moore, Robert M. Hicks, Jay Achar, Farhana Amanullah, Pennan Barry, Mercedes Becerra, Domnica I. Chiotan, Peter C. Drobac, Jennifer Flood, Jennifer Furin, Medea Gegia, Petros Isaakidis, Andrei Mariandyshev, Iveta Ozere, N. Sarita Shah, Alena Skrahina, Elena Yablokova, James A. Seddon, Anneke C. Hesseling
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 441-450 (2019)
Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (
Externí odkaz:
https://doaj.org/article/92f352615fe24d6787c5887e0c07cc98
Autor:
James A. Seddon, Anthony J. Garcia-Prats, Susan E. Purchase, Muhammad Osman, Anne-Marie Demers, Graeme Hoddinott, Angela M. Crook, Ellen Owen-Powell, Margaret J. Thomason, Anna Turkova, Diana M. Gibb, Lee Fairlie, Neil Martinson, H. Simon Schaaf, Anneke C. Hesseling
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. Treating individuals with MDR-TB infection to prevent progression to disease could be an effective public health strategy. Young children are
Externí odkaz:
https://doaj.org/article/a134014bc6634d18a556e22c01eb8f43
Autor:
Pauline Howell, Jay Achar, G. Khai Lin Huang, Andrei Mariandyshev, H. Simon Schaaf, Anthony J. Garcia-Prats
Publikováno v:
Pathogens, Vol 11, Iss 4, p 381 (2022)
Children affected by rifampicin-resistant tuberculosis (RR-TB; TB resistant to at least rifampicin) are a neglected group. Each year an estimated 25,000–30,000 children develop RR-TB disease globally. Improving case detection and treatment initiati
Externí odkaz:
https://doaj.org/article/9fa1303520ca4940a29368273f23aa73
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 11:S72-S78
There has been much recent progress on control of the tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics globally. However, advances in children have lagged behind, and TB-HIV coinfection continues to be a major driver of pediatric mo